RT Journal Article
SR Electronic
T1 A possible role of immunopathogenesis in COVID-19 progression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.28.20083089
DO 10.1101/2020.04.28.20083089
A1 Anft, Moritz
A1 Paniskaki, Krystallenia
A1 Blazquez-Navarro, Arturo
A1 Doevelaar, Adrian
A1 Seibert, Felix S.
A1 Hoelzer, Bodo
A1 Skrzypczyk, Sarah
A1 Kohut, Eva
A1 Kurek, Julia
A1 Zapka, Jan
A1 Wehler, Patrizia
A1 Kaliszczyk, Sviatlana
A1 Bajda, Sharon
A1 Thieme, Constantin J.
A1 Roch, Toralf
A1 Justine Konik, Margarethe
A1 Brenner, Thorsten
A1 Tempfer, Clemens
A1 Watzl, Carsten
A1 Dolff, Sebastian
A1 Dittmer, Ulf
A1 Westhoff, Timm H.
A1 Witzke, Oliver
A1 Stervbo, Ulrik
A1 Babel, Nina
YR 2020
UL http://medrxiv.org/content/early/2020/05/02/2020.04.28.20083089.abstract
AB Background The efficacy of the humoral and cellular immunity determines the outcome of viral infections. An appropriate immune response mediates protection, whereas an overwhelming immune response has been associated with immune-mediated pathogenesis in viral infections. The current study explored the general and SARS-CoV-2 specific cellular and humoral immune status in patients with different COVID-19 severities.Methods In this prospective study, we included 53 patients with moderate, severe, and critical COVID-19 manifestations comparing their quantitative, phenotypic, and functional characteristics of circulating immune cells, SARS-CoV-2 antigen specific T-cells, and humoral immunity.Results Significantly diminished frequencies of CD8+T-cells, CD4+ and CD8+T-cell subsets with activated differentiated memory/effector phenotype and migratory capacity were found in circulation in patients with severe and/or critical COVID-19 as compared to patients with moderate disease. Importantly, the improvement of the clinical courses from severe to moderate was accompanied by an improvement in the T-cell subset alterations. Furthermore, we surprisingly observed a detectable SARS-CoV-2-reactive T-cell response in all three groups after stimulation with SARS-CoV-2 S-protein overlapping peptide pool already at the first visit. Of note, patients with a critical COVID-19 demonstrated a stronger response of SARS-CoV-2-reactive T-cells producing Th1 associated inflammatory cytokines. Furthermore, clear correlation between antibody titers and SARS-CoV-2-reactive CD4+ frequencies underscore the role of specific immunity in disease progression.Conclusion Our data demonstrate that depletion of activated memory phenotype circulating T-cells and a strong SARS-CoV-2-specific cellular and humoral immunity are associated with COVID-19 disease severity. This counter-intuitive finding may have important implications for diagnostic, therapeutic and prophylactic COVID-19 management.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on request from the authors